Loading insider details...
Beta
Latest Form 4 (Aug 25, 2026): Sale of 415 TEVA shares, $15.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 25, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale | 415 | $15.5K |
| Jun 8, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 14,492 | n/a |
| Jun 1, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 7,242 | n/a |
| Jun 9, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 9,632 | n/a |
| Jun 17, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 21,108 | n/a |
| Jun 10, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 9,632 | n/a |
| Aug 7, 2023 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 15,810 | n/a |
| Jun 20, 2023 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 21,108 | n/a |
| Aug 8, 2022 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 15,810 | n/a |
| Jun 16, 2022 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 14,479 | n/a |